Replies to post #439372 on Anavex Life Sciences Corp (AVXL)

[Kmadd]

I think people are missing the follow-up paragraph to the meeting discussion where they say;

"Pursuant to discussion at the meetings, Anavex initiated the process for submitting a Marketing Authorisation application to the EMA with the submission of the Centralised Procedure request with the goal of the Authorisation allowing direct access to the market of the European Union for oral blarcamesine for the treatment of Alzheimer’s disease."

I take this as the meeting outlined the plan for approval, and Anavex further initiated the plan by submitting the MAA.